In contrast, the in vivo treatment of patient #1 PDX tumor-bearing mice confirmed the parallel ∼ 2.5-fold upregulation of EGFR (see Fig. 1G) and AREG (Fig. 2F). This evidence concerns the gene EGFR and neoplasm.